Olaparib benefits relapsed ovarian cancer patients, with BRCA1/2 mutation: Lancet Dr Satabdi Saha25 May 2021 9:30 AM ISTRecent research , put forth in The Lancet Oncology, has highlighted Olaparib to be effective in patients with relapsed ovarian cancer and BRCA1/2...
New experimental drug cagrilintide and semaglutide 2.4 mg combo effective for weight loss in obese: Study Hina Zahid22 May 2021 9:00 AM ISTUSA: A combination of cagrilintide and semaglutide 2.4 mg is safe, well-tolerated, and causes more weight loss than semaglutide 2.4 mg alone in people...
CGM may help prevent blood sugar swings in preterm infants in ICU: Lancet Medha Baranwal21 May 2021 11:30 AM ISTUK: The use of real-time Continuous glucose monitoring (CGM) in preterm infants requiring intensive care can aid earlier detection and prevention of...
Clopidogrel better than aspirin for long-term maintenance after stenting: HOST-EXAM Trial Hina Zahid20 May 2021 9:00 AM ISTSouth Korea: Clopidogrel monotherapy is superior to aspirin monotherapy for long-term chronic maintenance following percutaneous coronary intervention...
Tocilizumab improved survival in patients hospitalized with severe COVID-19: Lancet Medha Baranwal18 May 2021 9:00 AM ISTUK: Treatment with tocilizumab improved survival and other clinical outcomes in COVID-19 patients hospitalized with hypoxia and systemic inflammation,...
ICSI doesn't Improve live birth rate compared to IVF if male partners have normal sperm parameters: Lancet Medha Baranwal15 May 2021 6:45 AM ISTIntracytoplasmic sperm injection (ICSI) does not improve the live birth rate than conventional IVF in couples with infertility in whom the male...
Use of two different vaccines associated with more side effects: Lancet Medha Baranwal14 May 2021 11:48 AM ISTUK: People aged 50 and older who received doses of both the COVID-19 vaccines Pfizer/BioNTech and AstraZeneca/Oxford experienced more mild and...
Science behind "increasing gap between two Covishield vaccine doses to 12-16 weeks Medha Baranwal13 May 2021 11:45 AM ISTIndia: A government panel has suggested increasing the gap between two doses of the Covishield COVID-19 vaccine to 12-16 weeks. However, no such...
Guided antiplatelet therapy efficacious and safe in percutaneous coronary intervention:Lancet Dr Satabdi Saha26 April 2021 9:47 AM ISTAccording to recent research reports published in The Lancet,Guided selection of antiplatelet therapy improved both composite and individual...
Rituximab treatment may increase ICU admissions, mortality in COVID-19 patients: Study Medha Baranwal24 April 2021 4:31 AM ISTFrance: The administration of rituximab in patients with inflammatory rheumatic and musculoskeletal diseases is associated with more severe COVID-19...
Injectable antipsychotics better than oral ones at preventing relapse in schizophrenia: Lancet Dr Satabdi Saha21 April 2021 8:30 AM ISTIn a recent development, researchers have noted that, among long-acting injectable antipsychotics (LAIs) and oral antipsychotics in managing...
Evidence supporting airborne transmission of Coronavirus overwhelming: Lancet Hina Zahid18 April 2021 2:26 PM ISTThere is consistent, strong evidence that the SARS-CoV-2 virus, which causes COVID-19, is predominantly transmitted through the air, according to a...
